摘要 |
PCT No. PCT/EP92/00572 Sec. 371 Date Jan. 17, 1994 Sec. 102(e) Date Jan. 17, 1994 PCT Filed Mar. 17, 1992 PCT Pub. No. WO92/19651 PCT Pub. Date Nov. 12, 1992.A luteinizing hormone releasing hormone antagonist peptide is provided which effectively decreases plasma levels of estrogens and androgens. The peptide exhibits increased levels of potency while at the same time minimizing histamine releasing properties, vascular permeability (or edematogenic effects), hypotension, poor water solubility an inadequate duration of action associated with luteinizing hormone releasing hormone antagonist peptides of the past.
|